8UP-19051-49027
3 vaccinations
3 coded responses
36 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 926 / CA
- Registered
- 2020-12-30
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-30
Registered in v-safe
-
2020-12-30
Dose 1 — Moderna
- 2020-12-30
-
2020-12-31
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2020-12-31
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
- 2021-01-01
- 2021-01-04
- 2021-01-05
- 2021-01-06
- 2021-01-13
- 2021-01-21
- 2021-01-27
-
2021-01-29
Dose 2 — Moderna
-
2021-01-30
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-31
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Swelling · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-02-02
- 2021-02-03
- 2021-02-04
- 2021-02-05
- 2021-02-12
- 2021-02-19
- 2021-02-26
-
2021-03-07
Survey response — day 35, dose 2MedDRA: Rhinorrhoea — Feeling: GoodFree text: Runny noseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-14
- 2021-04-30
- 2021-08-01
-
2022-01-14
Dose 3 — ModernaCo-administered: Tetanus
-
2022-01-15
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
- 2022-01-16
- 2022-01-18
- 2022-01-19
- 2022-01-20
- 2022-01-21
- 2022-01-28
-
2022-02-04
Survey response — day 21, dose 3MedDRA: Diarrhoea, Vomiting — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Diarrhea, vomitingMedDRA releases: 2024-11 · check-in free text available
- 2022-02-11
- 2022-02-19
- 2022-02-26
- 2022-04-15
- 2022-07-15
-
2023-01-14
Survey response — 12 months, dose 3MedDRA: Cough — Feeling: Good · Be unable to do your normal daily activitiesMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-30 | Moderna | |
| 2 | 2021-01-29 | Moderna | |
| 3 | 2022-01-14 | Moderna | Tetanus |
Call center
1 call center case
1 priority 2/3 (triaged and no follow up)
Free text
Release 5 — day 35, dose 2
Symptoms: Runny nose
Release 11 — day 21, dose 3
Symptoms: Diarrhea, vomiting
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Diarrhoea | · | · | ✓ |
| SD | Rhinorrhoea | ✓ | ✓ | ✓ |
| SD | Vomiting | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release